Phathom Pharmaceuticals Inc (PHAT)
10.75
-0.14
(-1.29%)
USD |
NASDAQ |
May 21, 16:00
10.75
0.00 (0.00%)
After-Hours: 19:19
Phathom Pharmaceuticals 1 Year Total Returns (Daily): -17.75% for May 20, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 20, 2024 | -17.75% |
| May 17, 2024 | -20.57% |
| May 16, 2024 | -14.55% |
| May 15, 2024 | -17.32% |
| May 14, 2024 | -22.81% |
| May 13, 2024 | -28.16% |
| May 10, 2024 | -23.37% |
| May 09, 2024 | -15.85% |
| May 08, 2024 | -18.15% |
| May 07, 2024 | -17.08% |
| May 06, 2024 | -12.23% |
| May 03, 2024 | -13.60% |
| May 02, 2024 | -11.35% |
| May 01, 2024 | -16.58% |
| April 30, 2024 | -15.61% |
| April 29, 2024 | -12.62% |
| April 26, 2024 | -10.09% |
| April 25, 2024 | -10.78% |
| April 24, 2024 | -12.39% |
| April 23, 2024 | -14.37% |
| April 22, 2024 | -14.84% |
| April 19, 2024 | -16.32% |
| April 18, 2024 | -4.63% |
| April 17, 2024 | -5.95% |
| April 16, 2024 | 0.50% |
| Date | Value |
|---|---|
| April 15, 2024 | 0.40% |
| April 12, 2024 | 15.89% |
| April 11, 2024 | 27.22% |
| April 10, 2024 | 46.40% |
| April 09, 2024 | 56.49% |
| April 08, 2024 | 44.29% |
| April 05, 2024 | 51.51% |
| April 04, 2024 | 34.24% |
| April 03, 2024 | 32.88% |
| April 02, 2024 | 37.25% |
| April 01, 2024 | 48.46% |
| March 28, 2024 | 55.04% |
| March 27, 2024 | 65.42% |
| March 26, 2024 | 69.63% |
| March 25, 2024 | 68.82% |
| March 22, 2024 | 72.19% |
| March 21, 2024 | 41.80% |
| March 20, 2024 | 41.84% |
| March 19, 2024 | 30.61% |
| March 18, 2024 | 25.45% |
| March 15, 2024 | 21.29% |
| March 14, 2024 | 9.13% |
| March 13, 2024 | 11.89% |
| March 12, 2024 | 12.38% |
| March 11, 2024 | 13.62% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.11%
Minimum
Jun 17 2022
125.9%
Maximum
Dec 15 2020
-15.08%
Average
-20.57%
Median
May 17 2024
1 Year Total Returns (Daily) Benchmarks
| Regeneron Pharmaceuticals Inc | 30.07% |
| Rhythm Pharmaceuticals Inc | 132.3% |
| Xeris Biopharma Holdings Inc | -29.31% |
| Kodiak Sciences Inc | -44.84% |
| Vera Therapeutics Inc | 421.5% |